← All trials
NCT01695148
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2012
- Primary completion
- Mar 1, 2013
- Completion date
- Jun 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 1228
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Johns Hopkins UniversityLead sponsor
- Johns Hopkins UniversityStudy director
- Tropical Diseases Research Centre, ZambiaCollaborator
- National Food and Nutrition Commission, ZambiaCollaborator
- HarvestPlusCollaborator
- Canadian International Development AgencyCollaborator
- Zambia Agriculture Research InstituteCollaborator
- Johns Hopkins UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.